Charmacy Pharmaceutical Co Ltd
02289
Company Profile
Business description
Charmacy Pharmaceutical Co Ltd operates within the pharmaceutical distribution industry, with a primary focus on the distribution of pharmaceutical products. The principal business activities encompass the wholesale of pharmaceuticals and related services, along with road transportation and cargo warehousing. The company's distribution network covers Southern China and surrounding areas including Fujian province. All the group's operations are located in China.
Contact
No. 235, Song Shan North Road
Longhu District
Guangdong Province
Shantou515041
CHNT: +86 75488109272
Sector
Healthcare
Stock type
Defensive
Industry
Medical Distribution
Fiscal Year End
31 December 2026
Employees
847
Stocks News & Analysis
stocks
ASX iron ore player downgraded ahead of earnings
Rising costs and delayed production drive fair value cut for ASX iron ore player.
stocks
Global tensions drive profitability for ASX energy provider
Supply disruptions turbocharge refining profits and lift earnings forecasts for ASX energy share.
stocks
ASX energy share undervalued ahead of earnings
Pricing strength outweighs temporary production headwinds.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,391.00 | 45.30 | 0.48% |
| CAC 40 | 8,666.63 | 52.81 | 0.61% |
| DAX 40 | 26,202.35 | 201.04 | 0.77% |
| Dow JONES (US) | 54,085.88 | 907.47 | 1.71% |
| FTSE 100 | 10,879.38 | 21.68 | 0.20% |
| HKSE | 25,881.20 | 28.28 | 0.11% |
| NASDAQ | 26,584.99 | 671.10 | 2.59% |
| Nikkei 225 | 66,107.46 | 2,149.93 | 3.36% |
| NZX 50 Index | 13,970.93 | 67.47 | 0.49% |
| S&P 500 | 7,736.52 | 136.02 | 1.79% |
| S&P/ASX 200 | 9,213.50 | 37.00 | 0.40% |
| SSE Composite Index | 3,873.56 | 51.27 | 1.34% |